Regulatory
June 30, 2023
First ten HER2-low patients dosed in Phase 2 basket trial using Affibody’s PET imaging agent ABY-025
Regulatory
March 18, 2023
Regulatory
January 4, 2023
First HER2-low patients enrolled in Phase 2 basket trial using Affibody’s PET imaging agent ABY-025
Regulatory
December 23, 2022
Regulatory
November 8, 2022
Regulatory
November 7, 2022
Affibody’s partner Rallybio Announces Positive Phase 1 Results for RLYB116
Regulatory
June 3, 2022